INTRODUCTION
Chronic wasting disease (CWD) is a prion disease occurring naturally in wild and captive mule deer, white-tailed deer, Rocky mountain elk and wild moose. CWD was described as spongiform encephalopathy in deer by Williams and Young 1 and amyloid plaques there by Gajdusek and his coworkers. [2] [3] [4] [5] We described early in 1990s the neuropathology of CWD in natural and experimental animals. [6] [7] [8] [9] Recently, the first CWD case in free-ranging reindeer (Rangifer tarandus tarandus) was diagnosed in southern Norway. 10 Neuropathologically, CWD is characterized by the presence of vacuolated neurons, spongiform change in the neuropil and, mostly in mule deer, by amyloid plaques. Previously we reported on strain fidelity in mouse-adapted CWD. 8 To characterize the inflammatory and neuritic elements adjacent to the amyloid deposits and to compare the amyloid plaques of mCWD to those occurring in other prion diseases we analyzed ultrastructure and three-dimensional structure of amyloid plaques in chronic wasting disease (CWD) transmitted to Tg20 transgenic mice overexpressing prion protein (PrP c ).
MATERIAL AND METHODS

Mice and inoculum
mCWD was serially propagated in tga20 mice. Here the 5 th passage of mCWD in tga20 mice was used. Homogenates from individual animals were used for the inoculation. Tga20 mice were anesthetized with ketamine and xylazine and intracerebrally inoculated into the left parietal cortex with 30 ml of prion-infected brain homogenate prepared from terminally ill mice. Mice were monitored three times weekly, and TSE was diagnosed according to clinical criteria including ataxia, kyphosis, stiff tail, hind leg clasp, and hind leg paresis. The incubation period was calculated from the day of inoculation to the day of terminal clinical disease.
Electron microscopy
For electron microscopy, animals were perfused with 4% paraformaldehyde and 1% glutaraldehyde in cacodylate buffer, pH 7.4, postfixed in 1% osmium tetoxide and embedded in Epon. The semithin sections from cerebral (CA1 region) and cerebellar cortices, corpus callosum, hippocampus and the brain stem were selected and stained with toluidine blue. Grids were examined in Jeol 1100 transmission electron microscope.
Immunohistochemistry
Immunohistochemistry was performed on 4 mm thick sections of formalin-fixed paraffin embedded blocks. Sections were stained for the following antibodies: anti-prion protein (mouse monoclonal, clone 6H4, 1:400, pretreatment: 98% formic acid, Prionics, Switzerland), anti-Iba1 (rabbit polyclonal, 1:100, pretreatment: citrate buffer pH 6,0; Wako, Japan) and anti-NFPmedium chain (goat polyclonal, 1:100, pretreatment: citrate buffer pH 6,0; Abcam, UK) were used. For visualization EnVisionC System-HRP (Dako, Denmark) was used. Finally, sections were counterstained with haematoxylin.
Immunofluorescence
For double immunofluorescence stainings, 4% formalin fixed and paraffin-embedded tissues from mice brain were used. Sections were mounted on tissue slides and processed routinely. The sections were then treated with citrate antigen retrieval solution (Target Retrieval Solution 10X Concentrate, pH6.0, Dako). Additionally, the sections were incubated in 98% formic acid. As primary antibodies, anti-Prion Protein (mouse monoclonal, clone 6H4, 1:200, Prionics), anti-CD68 (rabbit polyclonal, 1:50, ProteinTech), anti-Iba1 (rabbit polyclonal, 1:50, Wako), anti-GFAP (rabbit polyclonal, 1:250, Dako) and anti-NFP (rabbit polyclonal, 1:500, ThermoFisher Scientific) were used. The fluorescent-labelled secondary antibodies were Alexa Fluor 488 (donkey antimouse, 1:200, Molecular Probes by Life Technologies) and Cy5 (goat anti-rabbit, 1:100, Jackson ImmunoResearch). The following combinations were applied: PrP (AF488)/CD68 (Cy5), PrP (AF488)/GFAP (Cy5), PrP (AF488)/Iba1 (Cy5) and PrP (AF488)/NFP (Cy5). Tissue slides were mounted with Prolong Gold antifade reagent (Molecular Probes by Life Technologies). The stained slides were evaluated with a confocal laser-scanning microscope (FV1200, Olympus, Japan).
Confocal imaging and reconstructions
Image sizes of 1024 » 1024 pixels were obtained to allow for the greatest spatial discrimination between pixels and maximise resolution potential in the XY dimension. Serial optical sections in the Z dimension were captured to allow for three-dimensional (3D) reconstruction. Imaris software version 8.1.2 (Bitplane AG Ò , Zurich, Switzerland) was used to generate the 3D reconstructed images. Confocal Z-stacks comprising up to 20 images were reconstructed into 3D animations. Solid skinned cell-surface rendering was using Surface function. The filament tracer mode was used for detection of neurons and astrocytes.
RESULTS
In the 5th passage mice amyloid plaques were present in the corpus callosum, the basal ganglia, the thalamus and the hippocampus but not in the cerebral and cerebellar cortex.
Immunohistochemistry
Immunohistochemical reactions revealed abundant microglial reaction around the amyloid plaques in all areas examined ( Fig. 1a ). Interestingly we found no dystrophic neurites around the plaques. The neurofilament immunoreactive processes were slightly rearranged in the vicinity of the amyloid deposits, but their morphology was not dystrophic (Fig. 1a ). On the other hand, dystrophic neurites were present in subcortical regions and in the brain stem, in a distance from amyloid deposits (Fig. 1b, c ).
Ultrastructure
Electron microscopy performed on perfusion-fixed brains confirmed our preliminary data obtained on material reversed from paraffin blocks to electron microscopy. 8 As described previously 8 two main types of plaques were present in mCWD: stellate unicentric and large multicentric plaques. However by electron microscopy some of the large plaques did not show the typical morphology of multicentric plaques. Thus by electron microcopy we were able to identify three main types of amyloid deposits in mCWD: large amyloid deposits ( Fig. 2, 3 ), unicentric plaques similar to kuru plaques in human prion diseases ( Fig. 4 ) and multicentric plaques reminiscent of plaques typical of GSS ( Fig. 5 ). Large and multicentric plaques were mainly located subpially while unicentric plaques were observed in the brain parenchyma and perivascularly ( Fig. 4 ). Ultrastructurally unicentric plaques were composed of bundles of amyloid fibrils deeply interwoven in the centre and radiating toward periphery (Fig. 4, 6 ). Perivascular plaques were those unicentric kuru plaques that were in close contact with cerebral brain vessels (Fig. 6 ). In the latter situation, amyloid fibrils were in close contact, or even merged with, with basal membranes. The most unique type of plaques were large subpial amyloid deposits Fig. 3 ). They were composed of large areas of amyloid fibrils but did not form "star-like" appearances of unicentric plaques. As described previously, all those plaques were totally devoid of dystrophic neuritic elements. However, numerous microglial cells invaded them ( Fig. 4, 7a, 7b ). Those cells looked very active with enlarged cisterns of FIGURE 2. Numerous plaques (arrows) in the thalamus. Note the lack of neuritic elements around the plaques; semi-thin section stained with tolouidine blue, x 40. endoplasmic reticulum. The outer membranes formed pockets were amyloid fibrils seemed to be "engulfed" (Fig. 5 ). Some cells were very dense and contained amorphous masses of even higher density. The labyrinth-like network of microglial processes was visible at the periphery and within plaques.
Confocal laser microscopy
Using confocal microscopy and threedimensional image analysis software (Imaris Version 8.2, Bitplane AG, Switzerland) we were able to study the structure of the amyloid plaques, their spatial organization and association with glial and neuronal cells. To obtain a more quantitative view of astrocytic and neuronal processes, processes were reconstructed as three-dimensional skinned models and measured using both Imaris automatic tracing and manual tracing. The plaques observed by confocal laser microscope were of the same types as those analyzed by electron microscopy: unicentric, multicentric and perivascular or large subpial amyloid deposits. In the brain sections that were double stained for PrP and neurofilament proteins, we recognized neuronal processes surrounding the plaques or, to some extent, intermingled with the amyloid fibres within the plaque ( Fig. 8 and 9 ). Interestingly, the axons did not show typical features of neuroaxonal dystrophy such as swellings or distortion, independently of the plaque type. In the brain sections double stained for the astroglial marker -GFAP and PrP, we observed astrogliosis with astrocytes surrounding and embracing the amyloid plaques but the processes of glial cells hardly entered the plaques. In all types of plaques double staining for microglia (Iba1) and PrP showed prominent microglial reaction around the plaques. The microglia were tightly enfolding the plaques with their processes deeply invading the interior of the plaque (Fig. 10 ).
DISCUSSION
We reported here on brain amyloid plaques in transgenic mice infected with CWD. Some of these plaques are reminiscent of other types of plaques described in prion diseases, however some as large amyloid deposits are not observed in other prion diseases.
In human prion diseases, plaques occur always in kuru, 11 in Gerstmann-Straussler-Scheinker (GSS) disease, variant CJD 12 and in a certain proportion of sporadic and iatrogenic Creutzfeldt-Jakob disease. 12, 13, 14 In kuru, plaques are very similar to unicentric plaques described here but contained sparse dystrophic neurites. 12 Interestingly, in captive mule deer CWD unicentric plaques also contained dystrophic neurites, but in Tg mice infected with FIGURE 8. Large subpial multicentric amyloid plaque surrounded by neuronal processes. Confocal laser microscopy, prion protein (6H4) -green, neurofilaments -red, magnification 600x, digital zoom 2.1x. Three-dimensional reconstruction of neuronal morphology by filament tracing software. CWD there are no dystrophic neurites around amyloid deposits. 6 Dystrophic neurites are degenerating dendrites or axonal terminals and preterminals which accumulate autophagic vacuoles and lysosomal electron-dense bodies. Those subcellular organelles are visible only by electron microscopy and should form a basis for definition of dystrophic neuritis. However, on a basis of correlative studies using light-and electron microscopy, this definition was extended to cover bulbs and rings observed at the light microscopy level. 15 Dystrophic neurites are abundant in Alzheimer disease (AD), another protein-misfolded disease 16 where abeta peptide amyloid spreads in prion-like fashion. 17 A caveat, what comes first -amyloid or neuroaxonal dystrophy seems solved by twophoton in vivo studies 18 using young APPswe/ PS1d9xYFP (B6C3-YFP) mice. In these mice plaques develop fast followed by dystrophic neurites. Our studies using transmission electron microscopy also showed that unicentric plaques are not neuritic and neurites do not invade but bypass the plaque as evidenced by image reconstruction of confocal microscopy. This study adds to the evidence that the plaques develop and dystrophic neurites can develop in response to certain types of plaques only.
Since our first description of microglia in plaques of GSS, 19 these cells became a target of intensive research. The basic tenet of this research is to answer the question on the role of microglia; are they a producer or just a scavenger of amyloid. 20 In mice with a disrupted gene for a microglial receptor Cx3cr1, 21 inoculated with 3 different strains of scrapie and BSE, the incubation period was shortened while the neuropathology pattern and microglia activation remained unaltered.
In conclusion, we reported here the diversity of PrP-amyloid deposits encountered in CWD -infected Tg20 mice. Generally, we confirmed the presence of abundant amyloid plaques in CWD-infected Tg20 samples reversed from paraffin blocks 8 and those published by us in captive mule deer. 6, 9 However, large amyloid deposits were observed for the first time.
Numerous microglial processes were visible within the plaques and at the periphery of plaques. The latter was particularly evident in unicentric deposits, a phenomenon described by us and the others in Gerstmann-Straussler-Scheinker disease (GSS) a quarter of century earlier, 19, 22, 23 but also in florid plaques in vCJD and kuru plaques in kuru. 12 Microglia are derived from c-kitC erythromyeloid precursor in the yolk sac. 24 The role of microglia in prion disease is unclear. It seems that they are infectious 25 and exhibit unique profile of RNAs typical for inflammatory disease. 26 They are readily observed in CJD 27 and in scrapie 28 and the intensity of microglial activation is dependent on the molecular type of PrP aggregate. 29 The presence of type 1 of PrP peptide correlates with abundance of CR3/43-immunostained microglia while the presence of the type 2 peptide not. In cases with both peptides present, the regional enhancement of microglia reaction correlates with the presence of peptide 1 of PrP. The exact role of microglia is not that clear 30 and it has been even suggested that microglia may play a neuroprotective role in prion diseases. 30 Alzheimer disease another neurodegenerative disease, also characterized by abundant plaque formation, is recently classified as "prion-like disease". 16, 31 The induction of amyloid beta plaques in cadaver died with CJD FIGURE 10. Amyloid unicentric plaque surrounded by microglial cells. Confocal laser microscopy, prion protein (6H4) -green, microglial cells (Iba1) -red, magnification 400x, digital zoom 1.8x.
following dura matter transplantation strongly suggests the prion-like mechanism. 17, 20, 32, 33 To sum up, we described here a range of amyloid deposits in CWD passaged through Tg20 transgenic animals. These deposits recapitulate those observed in naturally occurring CWD in mule deer but they are devoid of dystrophic neurites. In contrast in human prion diseases amyloid plaques are surrounded by numerous (GSS, vCJD) or sparse (sCJD, kuru) dystrophic neurites. Both electron microscopy and confocal laser microscopy showed numerous microglial processes within the plaques and at the periphery of plaques in mCWD.
